In 2020, the EU dental bone graft substitutes market size was valued at €151 million with allograft products driving the growth. Despite COVID-19, the market size is expected to increase over the forecast period and reach €277.7 million at a CAGR of 9.1% by 2027. Currently, over 50% of the dental bone graft substitutes market share in Europe is dominated by two main competitors – Geistlich and Botiss Biomaterials.

Both patient demand and a growing number of general practitioners (GPs) placing implants are driving the European market for dental bone graft substitutes forward by increasing the volume of dental implant procedures. Under this scenario, there is an increase in the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw before the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.

Even under the presence of limiting regulatory barriers, allograft products are showing double-digit growth in Europe and demand is forecasted to grow through 2027.

HOW HAS COVID-19 IMPACTED THE DENTAL BONE GRAFT SUBSTITUTES MARKET IN EUROPE?

In 2020, Europe’s dental bone graft substitute and other biomaterials market declined by 31% when compared to 2019 as a result of the COVID-19 pandemic. However, this market is expected to recover and exceed the pre-COVID levels by 2022.

The dental bone graft substitute and other biomaterials market, and all of the segments, were negatively impacted by COVID-19. Closures of non-essential businesses (including dental facilities), increased unemployment, and reduced patient volumes are all factors affecting the growth. As non-essential businesses emerge from lockdowns and closures, they will be expected to comply with COVID-19 social distancing and sanitizing regulations. As a result, practitioners have been reported to prioritize more urgent and profitable procedures to recoup some of the losses incurred during the lockdown periods.

MAJOR SEGMENTS COVERED IN THE DENTAL BONE GRAFT SUBSTITUTES MARKET REPORT SUITE

While this report suite contains all applicable market data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

• Dental Bone Graft Substitutes Market- MedCore – The market for dental bone graft substitutes is segmented into allograft, xenograft, and synthetic markets.
• Dental Growth Factor Market – MedCore – The market for dental growth factor is comprised of the Emdogain market.
• Dental Barrier Membranes Market – MedCore – The market for dental barrier membranes is separated into resorbable and non-resorbable membrane markets.

WHO ARE THE TOP DENTAL BONE GRAFT SUBSTITUTES / BIOMATERIALS COMPANIES IN EUROPE?

Of the many companies in the EU dental bone graft substitutes market, Geistlich maintained its leading position in the European dental biomaterial market, owing to its dominant presence in the dental bone graft substitute and dental barrier membrane markets. Botiss Biomaterials was the second leading dental biomaterial company in Europe. The company continues to benefit from its distribution partnership with Straumann. Other notable competitors include Zimmer Biomet, Non-Profit Tissue Banks, BioHorizons and numerous dental implant companies which have entered the dental biomaterial market.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Forecasts Until 2027, and Historical Data to 2017
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• COVID19 Impact on the Dental Implant market
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

 Research Scope Summary

FREE Sample Report